Gerwin R.
- Country
- The Netherlands
- Department
- Neurology
Research Overview
- Evaluation of Tranexamic Acid in Reducing Surgical Intervention in Patients with Chronic Subdural Hematoma: A Randomized Controlled Trial
- A Phase 2 Randomized, Placebo-Controlled, Double-Blind, Parallel-Group Study to Evaluate the Efficacy and Safety of MK-2214 in Participants with Early Alzheimer's Disease
- A Phase 2/3, Double-Blind, Placebo-Controlled Study of BHV-8000 in Participants with Early Parkinson’s Disease
Data & Insights
Has run more than one trial at 66 of 203 partner sites.
Specializations
Neurosurgical Research
The investigator specializes in the treatment of chronic subdural hematoma, focusing on innovative non-surgical therapeutic approaches that could potentially reduce the need for operative interventions.
- Conservative Treatment Methods
- Blood-Related Disorders
- Neurological Conditions
Their research explores the therapeutic potential of tranexamic acid in managing intracranial bleeding conditions.
Clinical Management
The investigator focuses on developing treatment strategies for neurological hemorrhagic conditions, with particular emphasis on minimizing surgical interventions through pharmaceutical approaches.
- Medical Conservative Therapy
- Hemorrhage Management
- Patient Monitoring
Their work encompasses long-term patient outcomes in neurosurgical conditions.
Therapeutic Innovation
The investigator examines alternative treatment pathways for intracranial hemorrhages, evaluating pharmacological interventions that could serve as primary treatment options.
- Drug-Based Interventions
- Treatment Optimization
- Clinical Outcomes
Their research aims to advance non-invasive treatment options for neurosurgical patients.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.